109

Last update : 01/01/2019

CASTOR - Study for the Comparison of the rAte of hoSpitalization for RSV bronchioliTis between preterm infants born at 32 weeks of gestational age or less without brOnchopulmonary dysplasia and full-teRm infants

Head : Miloradovich Tatiana, Abbott France

Main objective

Compare the rate of hospitalization for bronchiolitis to RSV between premature children born <= 32 weeks of gestational age without bronchopulmonary dysplasia (BPD) and full-term children, during the 2008-2009 RSV season

Inclusion criteria

- All aged less than 6 months at the beginning of the RSV epidemic season
- Very premature: born at 32 weeks of gestational age or less, without Bronchopulmonary Dysplasia (BPD)
- Full-Term: born between 39 and 41 weeks of gestational age

Last update : 01/01/2019

IDALGIA - Study of predictive factors of the induced pain linked to gestures in rheumatology

Head : Payen-Champenois Catherine, Brisol-Myers Squibb
Schmidely Nathalie, Brisol-Myers Squibb

Version 1

110

Last update : 09/05/2017

IDALGIA - Study of predictive factors of the induced pain linked to gestures in rheumatology

Head : Payen-Champenois Catherine, Brisol-Myers Squibb
Schmidely Nathalie, Brisol-Myers Squibb

Main objective

Evaluate the frequency of the various types of gestures and the intensity of the associated pain
Evaluate the various therapeutic preventive and curative approaches for pain linked to gestures in rheumatology

Inclusion criteria

For the gesture observatory: adult patient consulting in rheumatology for which the rheumatologist deems that it is necessary to immediately perform a diagnostic or therapeutic gesture

For the Study portion: patient eligible in the Observatory for which the rheumatologist has scheduled or has deemed immediately necessary, during this consultation, a one-off gesture (puncture and/or unilateral infiltration or an infiltration of the lumber spine).

Last update : 09/05/2017

- Assessment of cardiovascular risk in primary care in France

Head : Piedbois Pascal
Thomas-Delecourt Florence, AstraZeneca

Version 3

111

Last update : 01/01/2020

- Assessment of cardiovascular risk in primary care in France

Head : Piedbois Pascal
Thomas-Delecourt Florence, AstraZeneca

Main objective

Evaluate the correlation between the cardiovascular risk estimated by the physician and the theoretical cardiovascular risk

Inclusion criteria

Adults 50 years and older

Last update : 01/01/2020

ELCAPA - Longitudinal Study on Elderly Cancer Patients: Impact of Comprehensive Geriatric Assessment

Head : Paillaud Elena, Médecine gériatrique - Albert Chenevier

Version 2

112

Last update : 01/01/2020

ELCAPA - Longitudinal Study on Elderly Cancer Patients: Impact of Comprehensive Geriatric Assessment

Head : Paillaud Elena, Médecine gériatrique - Albert Chenevier

Main objective

The general aim of ELCAPA is to identify the impact of comprehensive geriatric assessment components on changes in planned cancer treatment, and to investigate the frequency where cancer treatment plans were not fulfilled (with reasons for non-fulfilment), as well as associated risk factors.

Inclusion criteria

Cancer patients aged 70 years and over that were referred for geriatric oncology consultation at Henri/Mondor/Paul Brousse and have undergone a comprehensive geriatric assessment (CGA).

Last update : 01/01/2020

ISAAC - International Study of Asthma and Allergies in Childhood in France

Head : Annesi-Maesano Isabella, UMRS 707 : Épidémiologie, systèmes d'information, modélisationÉpidémiologie des maladies allergiques et respiratoires EPAR

Version 1

113

Last update : 09/05/2017

ISAAC - International Study of Asthma and Allergies in Childhood in France

Head : Annesi-Maesano Isabella, UMRS 707 : Épidémiologie, systèmes d'information, modélisationÉpidémiologie des maladies allergiques et respiratoires EPAR

Main objective

To establish a global map of the prevalence of childhood allergic diseases and to determine the risk factors for these diseases by comparing contrasting population groups based on a particularly strong or weak prevalence.

The ISAAC study consists of three phases:
The objective of Phase I is to assess the prevalence of asthma, allergic rhinitis and eczema by using a simple questionnaire and possible video questionnaire (for asthma), in representative samples of children from two age groups: 13-14 years old (obligatory for all centres) and 6-7 years old (optional).
Phase II aims to identify the risk factors and treatment procedures for allergic diseases through a more detailed study of selected population groups with relatively high or low prevalence rates suggested during Phase I.
Phase III aims to assess the trends in allergy prevalence.
As such, the Phase I protocol will be repeated in areas that participated in this phase.

Inclusion criteria

- primary school children
- between 8 and 13 years old

Last update : 09/05/2017

ARISTOTE - Use of Fondaparinux in current clinical practice for thromboprophylaxis following major orthopedic surgery in France

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Version 1

114

Last update : 01/01/2019

ARISTOTE - Use of Fondaparinux in current clinical practice for thromboprophylaxis following major orthopedic surgery in France

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Main objective

• Describe the actual conditions of use of ARIXTRA® 2.5 mg in routine practice after an orthopedic surgical intervention.
• Observe the frequency of occurrence of VTEs during the 6 weeks following the initiation of the treatment via ARIXTRA® 2.5 mg.
• Observe the frequency of occurrence of major bleeding during the 6 weeks following the initiation of the treatment via ARIXTRA® 2.5 mg.

Inclusion criteria

• Patients of at least 18 years of age.
• Patients hospitalized in orthopedic surgery and for whom a treatment via ARIXTRA® 2.5 mg is initiated.

Last update : 01/01/2019